These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25992895)

  • 1. The health system and population health implications of large-scale diabetes screening in India: a microsimulation model of alternative approaches.
    Basu S; Millett C; Vijan S; Hayward RA; Kinra S; Ahuja R; Yudkin JS
    PLoS Med; 2015 May; 12(5):e1001827; discussion e1001827. PubMed ID: 25992895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age.
    Johnson SL; Tabaei BP; Herman WH
    Diabetes Care; 2005 Feb; 28(2):307-11. PubMed ID: 15677784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are people at high risk for diabetes visiting health facility for confirmation of diagnosis? A population-based study from rural India.
    Srinivasapura Venkateshmurthy N; Soundappan K; Gummidi B; Bhaskara Rao M; Tandon N; Reddy KS; Prabhakaran D; Mohan S
    Glob Health Action; 2018; 11(1):1416744. PubMed ID: 29334333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the risk of mortality for people who are screen positive in a diabetes screening programme but who do not have diabetes on biochemical testing? Diabetes screening programmes from a public health perspective.
    Spijkerman A; Griffin S; Dekker J; Nijpels G; Wareham NJ
    J Med Screen; 2002; 9(4):187-90. PubMed ID: 12518011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for type 2 diabetes in the Iranian national programme: a preliminary report.
    Azizi F; Guoya MM; Vazirian P; Dolatshati P; Habbibian S
    East Mediterr Health J; 2003; 9(5-6):1122-7. PubMed ID: 16450546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discover diabetes: screening for diabetes mellitus in the Waikato.
    Lawrenson RA; Dunn PJ; Jury D; Sceats J
    N Z Med J; 1993 Dec; 106(969):522-4. PubMed ID: 8183493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Approaches for Detecting Glucose Disorders.
    Lee CM; Colagiuri S
    Curr Diabetes Rev; 2016; 12(1):42-50. PubMed ID: 25845374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted screening for prediabetes and undiagnosed diabetes in a community setting in India.
    Sathish T; Shaw JE; Tapp RJ; Wolfe R; Thankappan KR; Balachandran S; Oldenburg B
    Diabetes Metab Syndr; 2019; 13(3):1785-1790. PubMed ID: 31235095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation and validation of diabetes risk score for urban Asian Indians.
    Ramachandran A; Snehalatha C; Vijay V; Wareham NJ; Colagiuri S
    Diabetes Res Clin Pract; 2005 Oct; 70(1):63-70. PubMed ID: 16126124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes and Hypertension in India: A Nationally Representative Study of 1.3 Million Adults.
    Geldsetzer P; Manne-Goehler J; Theilmann M; Davies JI; Awasthi A; Vollmer S; Jaacks LM; Bärnighausen T; Atun R
    JAMA Intern Med; 2018 Mar; 178(3):363-372. PubMed ID: 29379964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congruence between the Indian Diabetes Risk Score and Australian Type 2 Diabetes Risk Assessment tool screening in Asian-Indians.
    Fernandez RS; Frost S
    Nurse Res; 2013 Nov; 21(2):36-9. PubMed ID: 24171636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Chinese diabetes risk score for screening of undiagnosed diabetes and abnormal glucose tolerance.
    Liu M; Pan C; Jin M
    Diabetes Technol Ther; 2011 May; 13(5):501-7. PubMed ID: 21406016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rates of false positives are likely in diabetes screening programmes in India.
    Bagcchi S
    BMJ; 2015 Jun; 350():h3535. PubMed ID: 26124505
    [No Abstract]   [Full Text] [Related]  

  • 15. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
    Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National patterns in diabetes screening: data from the National Health and Nutrition Examination Survey (NHANES) 2005-2012.
    Kiefer MM; Silverman JB; Young BA; Nelson KM
    J Gen Intern Med; 2015 May; 30(5):612-8. PubMed ID: 25533392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial impact and cost of a nationwide population screening campaign for diabetes in Brazil: a follow up study.
    Toscano CM; Duncan BB; Mengue SS; Polanczyk CA; Nucci LB; Costa e Forti A; Fonseca CD; Schmidt MI;
    BMC Health Serv Res; 2008 Sep; 8():189. PubMed ID: 18808662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients.
    O'Brien MJ; Lee JY; Carnethon MR; Ackermann RT; Vargas MC; Hamilton A; Mohanty N; Rittner SS; Park JN; Hassan A; Buchanan DR; Liu L; Feinglass J
    PLoS Med; 2016 Jul; 13(7):e1002074. PubMed ID: 27403739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for diabetes.
    Backholer K; Chen L; Shaw J
    Pathology; 2012 Feb; 44(2):110-4. PubMed ID: 22228253
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.